pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Hematology · news · pharmadog
← back to Hematology
News · Hematology
406
stories
11h
Ultragenyx, after setbacks, nabs first gene therapy approval
biopharma dive
13h
STAT+: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and more
stat
15h
FDA approves Ultragenyx's gene therapy Genglycos for glycogen storage disorder
endpoints
18h
Meet Aletta: The first FDA approved robotic blood draw device
fiercebiotech
1d
FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia
fda press
1d
B. Braun Medical Inc. Issues Voluntary North American Recall of Excel® Lactated Ringers Injection, 1000mL Due to the Presence of Particulate Matter
fda recalls
1d
Amgen abandoning $500M+ Crohn’s collab won’t derail TScan’s pipeline strategy
fiercebiotech
1d
FDA Authorizes First-Of-Its-Kind Robotic Blood Draw Device
fda press
1d
Kolon TissueGene cuts 37 US staffers after Phase 3 fail
biospace
1d
Amylyx’s redemption story, Summit’s survival woes, Definium’s anxiety win, more
biospace
1d
Tolerance Bio jumps into phase 2 with $260M deal for thymus-targeting fusion protein
fiercebiotech
1d
Opinion: AI has created a shadow medical system
stat
1d
She grew up unvaccinated. Now she’s a leading voice for science — and empathy
stat
1d
Novo takes first round of oral obesity duel. Can it stay ahead of Lilly?
biospace
2d
STAT+: Real-world psilocybin data suggest need for close monitoring
stat
2d
AstraZeneca scores in lung cancer; Sandoz inks a China deal
biopharma dive
2d
A ‘renaissance for biomedicine’: human brain organoids model development for 5 years
fiercebiotech
2d
Amylyx’s bet on a GLP-1 blocker pays off
biopharma dive
2d
Amylyx reports Phase 3 win for GLP-1 antagonist avexitide in post-bariatric hypoglycemia
endpoints
2d
STAT+: Amylyx endocrine drug succeeds in pivotal study
stat
2d
Craif raises $33M to boost work on its urine test for cancer
fiercebiotech
3d
Amylyx readies approval push after GLP-1 inhibitor halves blood sugar crashes in ph. 3 win
fiercebiotech
3d
EyePoint plummets on pivotal data for main drug
biopharma dive
3d
AstraZeneca scraps Phase 3 trial of new bispecific in lung cancer
biopharma dive
3d
Slate, Fulcrum to combine in reverse merger
biopharma dive
3d
AstraZeneca pulls plug on late-stage lung cancer trial, taking another clinical blow
biospace
3d
AstraZeneca pulls plug on late-stage lung cancer trial, taking another clinical blow
biospace
3d
How AI-enabled Software as Medical Devices are Reshaping Regulatory Routes and Medicine
biospace
4d
Recon: FDA approves Zenbexus for multiple myeloma; NSAI seeks buyer for its MDR notified body business
raps
6d
STAT+: PBMs agree to display TrumpRx drug prices
stat
← prev
page 1 of 14
next →
